Thrombo-prophylaxis in Danish surgical departments - Status 2005 and 25 years' development;Tromboseprofylakse på kirurgiske afdelinger i Danmark - Status 2005 og 25 års udvikling

Ugeskrift for Laeger

Volumn 170, Issue 11, 2008, Pages 947-951

  Schmidt, Lasse M ^a   Foli Andersen, Nina J ^a   Rasmussen, Hans Morten Schnack ^a   Wille Jørgensen, Peer A ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; DENMARK; HEALTH PERSONNEL ATTITUDE; HOSPITAL DEPARTMENT; HUMAN; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREMEDICATION; QUESTIONNAIRE; RISK FACTOR; SURGERY; THROMBOSIS;

ANTICOAGULANTS; ATTITUDE OF HEALTH PERSONNEL; DENMARK; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTRAOPERATIVE COMPLICATIONS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; QUESTIONNAIRES; RISK FACTORS; SURGERY DEPARTMENT, HOSPITAL; SURGICAL PROCEDURES, OPERATIVE; THROMBOSIS;

EID: 41949100230     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wille-Jørgensen P, Jørgensen LN, Crawford M. Asymptomatic deep vein thrombosis and the development of postthrombotic syndrome: A systematic review and meta-analysis. Thrombos Haemostasis 2005;93:236-41.
2. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:338S-400S.
3. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;11:2384-90.
4. Jørgensen T. Tromboseprofylakse i Danmark, resultat af en enqueteundersøgelse. Ugeskr Læger 1982;144:1600-1.
5. Wille-Jørgensen P, Hauch O. Tromboseprofylakse i Danmark. Ugeskr Læger 1987;149:1811-4.
6. Lausen I, Rasmussen MS, Wille-Jørgensen P. Forebyggelse af postoperativ tromboemboli i Danmark. Ugeskr Læger 1992;154:3763-6.
7. Sørensen S, Sørensen J. Rasmussen MS et al. Principper for tromboseprofylakse på kirurgiske afdelinger i Danmark. Ugeskr Læger 1997;159:1261-4.
8. Rasmussen MS, Priyan U, Wille-Jørgensen P. Brug af tromboseprofylakse på danske kirurgiske afdelinger i år 2000. Ugeskr Læger 2005;167:43-6.
9. Handoll HHG, Farrar MJ, McBirnie J et al. Prophylaxis using heparin, low molecular weight heparin and physical methods against deep vein thrombosis and pulmonary embolism in hip fracture surgery. Cochrane Database Syst Rev 2002;(4):CD000305.
10. Wille-Jørgensen P, Thorup J, Holst-Christensen J et al. Heparin with and without graded compression stockings in prevention of postoperative thromboembolic complications of major abdominal surgery. Br J Surg 1985;72:579-81.
11. Agnelli G, Bergqvist D, Cohen AT et al. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005;92:1212-20.
12. Hull RD, Pineo GF, Stein PD et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med 2001;161:1952-60.
13. Lumpkin M. FDA public health advisory: Anesthesiology 1998;88:27A-28A.
14. Bergqvist D, Lindblad B, Mätzsch T. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia - is there a risk? Acta Anaesthesiol Scand 1992;36:605-9.
15. Nielsen JD, Rasmussen HMS, Husted SE. Den antitrombotiske behandlede patient. Ugeskr Læger 2006;168:4296-9.
16. Kakkar V, Corrigan T, Fossard D et al. Prevention of fatal postoperative pulmonary embolism by low doses of subcutaneous heparin: an international multicentre trial. Lancet 1975;2:45-51.
17. Leizorovicz A, Haugh MC, Chapuis FR et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992;305:913-20.
18. Nielsen JD. Tromboseprofylakse ved hoftefrakturkirurgi og hofte- og knæalloplastik. Ugeskr Læger 2005;167:2261-5.
19. Eikelbloom JW, Quilan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of tha randomised trials. Lancet 2001;358:9-15.
20. Bergqvist D, Agnelli G, Cohen AT et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.